4.8 Article

Cell Aggregation Culture Induces Functional Differentiation of Induced Hepatocyte-like Cells through Activation of Hippo Signaling

Journal

CELL REPORTS
Volume 25, Issue 1, Pages 183-198

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2018.09.010

Keywords

-

Categories

Funding

  1. Ministry of Education, Culture, Sports, Science, and Technology of Japan
  2. Japan Society for the Promotion of Science [25670146, 15J03606, 16H01850, 18H05102]
  3. Core Research for Evolutional Science and Technology (CREST) Program of the Japan Agency for Medical Research and Development (AMED)
  4. Program for Basic and Clinical Research on Hepatitis of AMED
  5. Uehara Memorial Foundation
  6. Life Science Foundation of Japan
  7. Hitachi Global Foundation
  8. Inamori Foundation
  9. Takeda Science Foundation
  10. Grants-in-Aid for Scientific Research [25670146, 18H05102, 16H01850, 15J03606] Funding Source: KAKEN

Ask authors/readers for more resources

Recent progress in direct lineage reprogramming has enabled the generation of induced hepatocyte-like (iHep) cells and revealed their potential as an alternative to hepatocytes for medical applications. However, the hepatic functions of iHep cells are insufficient compared with those of primary hepatocytes. Here, we show that cell-aggregate formation can rapidly induce growth arrest and hepatic maturation of iHep cells through activation of Hippo signaling. During formation of iHep cell aggregates, Yap inactivation is induced by actin reorganization and intercellular adhesion, leading to upregulation of Hnf1 alpha expression in the absence of the Yap/Tead/Chd4 transcriptional repressor unit. Hnf1 alpha then acts as a central transcription factor that regulates liver-enriched gene expression in iHep cell aggregates and induces functional differentiation of iHep cells. Moreover, iHep cell aggregates efficiently reconstitute injured liver tissues and support hepatic function after transplantation. Thus, iHep cell aggregates may provide insights into basic research and potential therapies for liver diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available